 | • レポートコード：GIR201114749 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：サービス・ソフトウェア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、医薬品開発におけるアウトソーシングの世界市場を調査対象にし、医薬品開発におけるアウトソーシングの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（臨床試験、新薬）、用途別分析（製薬産業、バイオテクノロジー産業、医療機器産業）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Charles River Laboratories、Parexel、Covance、PRA Health Sciences、ICON、PPD、Quintiles Transnational ・企業別売上、市場シェア ・医薬品開発におけるアウトソーシングの地域別市場分析 ・医薬品開発におけるアウトソーシングの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・医薬品開発におけるアウトソーシングのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・医薬品開発におけるアウトソーシングのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・医薬品開発におけるアウトソーシングの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・医薬品開発におけるアウトソーシングの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・医薬品開発におけるアウトソーシングの種類別市場規模2015-2020：臨床試験、新薬 ・医薬品開発におけるアウトソーシングの用途別市場規模2015-2020：製薬産業、バイオテクノロジー産業、医療機器産業 ・医薬品開発におけるアウトソーシングの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Outsourcing in Drug Development market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Outsourcing in Drug Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Outsourcing in Drug Development market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Outsourcing in Drug Development market has been segmented into:
Clinical Trials
New Drug Application
By Application, Outsourcing in Drug Development has been segmented into:
Pharmaceutical Industries
Biotechnology Industries
Medical Device Industries
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Outsourcing in Drug Development market presented in the report. This section sheds light on the sales growth of different regional and country-level Outsourcing in Drug Development markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Outsourcing in Drug Development market.
The report offers in-depth assessment of the growth and other aspects of the Outsourcing in Drug Development market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Outsourcing in Drug Development Market Share Analysis
Outsourcing in Drug Development competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Outsourcing in Drug Development sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Outsourcing in Drug Development sales, revenue and market share for each player covered in this report.
The major players covered in Outsourcing in Drug Development are:
Charles River Laboratories
Parexel
Covance
PRA Health Sciences
ICON
PPD
Quintiles Transnational
1 Outsourcing in Drug Development Market Overview
1.1 Product Overview and Scope of Outsourcing in Drug Development
1.2 Classification of Outsourcing in Drug Development by Type
1.2.1 Global Outsourcing in Drug Development Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Outsourcing in Drug Development Revenue Market Share by Type in 2019
1.2.3 Clinical Trials
1.2.4 New Drug Application
1.3 Global Outsourcing in Drug Development Market by Application
1.3.1 Overview: Global Outsourcing in Drug Development Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical Industries
1.3.3 Biotechnology Industries
1.3.4 Medical Device Industries
1.4 Global Outsourcing in Drug Development Market by Regions
1.4.1 Global Outsourcing in Drug Development Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Outsourcing in Drug Development (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Outsourcing in Drug Development Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Outsourcing in Drug Development Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Outsourcing in Drug Development Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Outsourcing in Drug Development Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Outsourcing in Drug Development Status and Prospect (2015-2025)
2 Company Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Charles River Laboratories SWOT Analysis
2.1.4 Charles River Laboratories Product and Services
2.1.5 Charles River Laboratories Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.2 Parexel
2.2.1 Parexel Details
2.2.2 Parexel Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Parexel SWOT Analysis
2.2.4 Parexel Product and Services
2.2.5 Parexel Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.3 Covance
2.3.1 Covance Details
2.3.2 Covance Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Covance SWOT Analysis
2.3.4 Covance Product and Services
2.3.5 Covance Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.4 PRA Health Sciences
2.4.1 PRA Health Sciences Details
2.4.2 PRA Health Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 PRA Health Sciences SWOT Analysis
2.4.4 PRA Health Sciences Product and Services
2.4.5 PRA Health Sciences Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.5 ICON
2.5.1 ICON Details
2.5.2 ICON Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ICON SWOT Analysis
2.5.4 ICON Product and Services
2.5.5 ICON Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.6 PPD
2.6.1 PPD Details
2.6.2 PPD Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 PPD SWOT Analysis
2.6.4 PPD Product and Services
2.6.5 PPD Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2018-2019)
2.7 Quintiles Transnational
2.7.1 Quintiles Transnational Details
2.7.2 Quintiles Transnational Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Quintiles Transnational SWOT Analysis
2.7.4 Quintiles Transnational Product and Services
2.7.5 Quintiles Transnational Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Outsourcing in Drug Development Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Outsourcing in Drug Development Players Market Share
3.2.2 Top 10 Outsourcing in Drug Development Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Outsourcing in Drug Development Revenue and Market Share by Regions
4.2 North America Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
4.3 Europe Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
4.5 South America Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
5 North America Outsourcing in Drug Development Revenue by Countries
5.1 North America Outsourcing in Drug Development Revenue by Countries (2015-2020)
5.2 USA Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
5.3 Canada Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
5.4 Mexico Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
6 Europe Outsourcing in Drug Development Revenue by Countries
6.1 Europe Outsourcing in Drug Development Revenue by Countries (2015-2020)
6.2 Germany Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
6.3 UK Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
6.4 France Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
6.5 Russia Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
6.6 Italy Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Outsourcing in Drug Development Revenue by Countries
7.1 Asia-Pacific Outsourcing in Drug Development Revenue by Countries (2015-2020)
7.2 China Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
7.3 Japan Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
7.4 Korea Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
7.5 India Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
8 South America Outsourcing in Drug Development Revenue by Countries
8.1 South America Outsourcing in Drug Development Revenue by Countries (2015-2020)
8.2 Brazil Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
8.3 Argentina Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Outsourcing in Drug Development by Countries
9.1 Middle East & Africa Outsourcing in Drug Development Revenue by Countries (2015-2020)
9.2 Saudi Arabia Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
9.3 UAE Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
9.4 Egypt Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
9.5 South Africa Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Outsourcing in Drug Development Revenue and Market Share by Type (2015-2020)
10.2 Global Outsourcing in Drug Development Market Forecast by Type (2019-2024)
10.3 Clinical Trials Revenue Growth Rate (2015-2025)
10.4 New Drug Application Revenue Growth Rate (2015-2025)
11 Global Outsourcing in Drug Development Market Segment by Application
11.1 Global Outsourcing in Drug Development Revenue Market Share by Application (2015-2020)
11.2 Outsourcing in Drug Development Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Industries Revenue Growth (2015-2020)
11.4 Biotechnology Industries Revenue Growth (2015-2020)
11.5 Medical Device Industries Revenue Growth (2015-2020)
12 Global Outsourcing in Drug Development Market Size Forecast (2021-2025)
12.1 Global Outsourcing in Drug Development Market Size Forecast (2021-2025)
12.2 Global Outsourcing in Drug Development Market Forecast by Regions (2021-2025)
12.3 North America Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
12.4 Europe Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
12.6 South America Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Outsourcing in Drug Development Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Outsourcing in Drug Development by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Outsourcing in Drug Development Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Outsourcing in Drug Development Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Charles River Laboratories Corporate Information, Location and Competitors
Table 6. Charles River Laboratories Outsourcing in Drug Development Major Business
Table 7. Charles River Laboratories Outsourcing in Drug Development Total Revenue (USD Million) (2017-2018)
Table 8. Charles River Laboratories SWOT Analysis
Table 9. Charles River Laboratories Outsourcing in Drug Development Product and Solutions
Table 10. Charles River Laboratories Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Parexel Corporate Information, Location and Competitors
Table 12. Parexel Outsourcing in Drug Development Major Business
Table 13. Parexel Outsourcing in Drug Development Total Revenue (USD Million) (2018-2019)
Table 14. Parexel SWOT Analysis
Table 15. Parexel Outsourcing in Drug Development Product and Solutions
Table 16. Parexel Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Covance Corporate Information, Location and Competitors
Table 18. Covance Outsourcing in Drug Development Major Business
Table 19. Covance Outsourcing in Drug Development Total Revenue (USD Million) (2017-2018)
Table 20. Covance SWOT Analysis
Table 21. Covance Outsourcing in Drug Development Product and Solutions
Table 22. Covance Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. PRA Health Sciences Corporate Information, Location and Competitors
Table 24. PRA Health Sciences Outsourcing in Drug Development Major Business
Table 25. PRA Health Sciences Outsourcing in Drug Development Total Revenue (USD Million) (2017-2018)
Table 26. PRA Health Sciences SWOT Analysis
Table 27. PRA Health Sciences Outsourcing in Drug Development Product and Solutions
Table 28. PRA Health Sciences Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. ICON Corporate Information, Location and Competitors
Table 30. ICON Outsourcing in Drug Development Major Business
Table 31. ICON Outsourcing in Drug Development Total Revenue (USD Million) (2017-2018)
Table 32. ICON SWOT Analysis
Table 33. ICON Outsourcing in Drug Development Product and Solutions
Table 34. ICON Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. PPD Corporate Information, Location and Competitors
Table 36. PPD Outsourcing in Drug Development Major Business
Table 37. PPD Outsourcing in Drug Development Total Revenue (USD Million) (2017-2018)
Table 38. PPD SWOT Analysis
Table 39. PPD Outsourcing in Drug Development Product and Solutions
Table 40. PPD Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Quintiles Transnational Corporate Information, Location and Competitors
Table 42. Quintiles Transnational Outsourcing in Drug Development Major Business
Table 43. Quintiles Transnational Outsourcing in Drug Development Total Revenue (USD Million) (2017-2018)
Table 44. Quintiles Transnational SWOT Analysis
Table 45. Quintiles Transnational Outsourcing in Drug Development Product and Solutions
Table 46. Quintiles Transnational Outsourcing in Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Outsourcing in Drug Development Revenue (Million USD) by Players (2015-2020)
Table 48. Global Outsourcing in Drug Development Revenue Share by Players (2015-2020)
Table 49. Global Outsourcing in Drug Development Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Outsourcing in Drug Development Revenue Market Share by Regions (2015-2020)
Table 51. North America Outsourcing in Drug Development Revenue by Countries (2015-2020)
Table 52. North America Outsourcing in Drug Development Revenue Market Share by Countries (2015-2020)
Table 53. Europe Outsourcing in Drug Development Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Outsourcing in Drug Development Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Outsourcing in Drug Development Revenue by Countries (2015-2020)
Table 56. South America Outsourcing in Drug Development Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Outsourcing in Drug Development Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Outsourcing in Drug Development Revenue Market Share by Countries (2015-2020)
Table 59. Global Outsourcing in Drug Development Revenue (Million USD) by Type (2015-2020)
Table 60. Global Outsourcing in Drug Development Revenue Share by Type (2015-2020)
Table 61. Global Outsourcing in Drug Development Revenue Forecast by Type (2021-2025)
Table 62. Global Outsourcing in Drug Development Revenue by Application (2015-2020)
Table 63. Global Outsourcing in Drug Development Revenue Share by Application (2015-2020)
Table 64. Global Outsourcing in Drug Development Revenue Forecast by Application (2021-2025)
Table 65. Global Outsourcing in Drug Development Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Outsourcing in Drug Development Picture
Figure 2. Global Outsourcing in Drug Development Revenue Market Share by Type in 2019
Figure 3. Clinical Trials Picture
Figure 4. New Drug Application Picture
Figure 5. Outsourcing in Drug Development Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical Industries Picture
Figure 7. Biotechnology Industries Picture
Figure 8. Medical Device Industries Picture
Figure 9. Global Outsourcing in Drug Development Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Outsourcing in Drug Development Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Outsourcing in Drug Development Revenue Market Share in 2019
Figure 18. Global Top 10 Players Outsourcing in Drug Development Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Outsourcing in Drug Development Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Outsourcing in Drug Development Revenue Market Share by Regions (2015-2020)
Figure 22. Global Outsourcing in Drug Development Revenue Market Share by Regions in 2018
Figure 23. North America Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 24. Europe Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 26. South America Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 28. North America Outsourcing in Drug Development Revenue Market Share by Countries (2015-2020)
Figure 29. North America Outsourcing in Drug Development Revenue Market Share by Countries in 2019
Figure 30. USA Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 31. Canada Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 33. Europe Outsourcing in Drug Development Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Outsourcing in Drug Development Revenue Market Share by Countries in 2019
Figure 35. Germany Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 36. UK Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 37. France Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 38. Russia Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 39. Italy Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Outsourcing in Drug Development Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Outsourcing in Drug Development Revenue Market Share by Countries in 2019
Figure 42. China Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 43. Japan Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 44. Korea Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 45. India Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 47. South America Outsourcing in Drug Development Revenue Market Share by Countries (2015-2020)
Figure 48. South America Outsourcing in Drug Development Revenue Market Share by Countries in 2019
Figure 49. Brazil Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Outsourcing in Drug Development Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Outsourcing in Drug Development Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 54. UAE Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Outsourcing in Drug Development Revenue and Growth Rate (2015-2020)
Figure 57. Global Outsourcing in Drug Development Revenue Share by Type (2015-2020)
Figure 58. Global Outsourcing in Drug Development Revenue Share by Type in 2019
Figure 59. Global Outsourcing in Drug Development Market Share Forecast by Type (2021-2025)
Figure 60. Global Clinical Trials Revenue Growth Rate (2015-2020)
Figure 61. Global New Drug Application Revenue Growth Rate (2015-2020)
Figure 62. Global Outsourcing in Drug Development Revenue Share by Application (2015-2020)
Figure 63. Global Outsourcing in Drug Development Revenue Share by Application in 2019
Figure 64. Global Outsourcing in Drug Development Market Share Forecast by Application (2021-2025)
Figure 65. Global Pharmaceutical Industries Revenue Growth Rate (2015-2020)
Figure 66. Global Biotechnology Industries Revenue Growth Rate (2015-2020)
Figure 67. Global Medical Device Industries Revenue Growth Rate (2015-2020)
Figure 68. Global Outsourcing in Drug Development Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Outsourcing in Drug Development Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Outsourcing in Drug Development Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
Figure 72. Europe Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
Figure 74. South America Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Outsourcing in Drug Development Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
創薬におけるアウトソーシングの世界市場 2020年 Market Overview The global Outsourcing in Drug Discovery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Outsourcing in …- 医療規制業務アウトソーシングの世界市場 2020年 Market Overview The global Healthcare Regulatory Affairs Outsourcing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 3712.9 million by 2025, from USD 3042.9 million in 2019…
- 生物製剤医薬品開発の世界市場 2020年 Market Overview The global Biologics Drug Development market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biologics Drug Dev…
- ファーマコビジランス（PV）アウトソーシングの世界市場 2020年 Market Overview The global Pharmacovigilance (PV) Outsourcing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pharmacovi…
- 医療機器アウトソーシングの世界市場 2020年 Market Overview The global Medical Device Outsourcing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.3% in the forecast period of 2020 to 2025 and will expected to reach USD 90620 million by 2025, from USD 63510 million in 2019. The Medical Dev…